Literature DB >> 21140683

Does surgical resection have a role in the treatment of large or multinodular hepatocellular carcinoma?

Giovanni Ramacciato1, Paolo Mercantini, Niccolò Petrucciani, Matteo Ravaioli, Alessandro Cucchetti, Massimo Del Gaudio, Matteo Cescon, Vincenzo Ziparo, Antonio Daniele Pinna.   

Abstract

Several effective treatments are available for patients with small solitary hepatocellular carcinomas (HCCs). Conversely, the management of patients with large or multinodular HCCs is controversial, and the role of surgical resection is not well defined. Between 2000 and 2006, 51 patients with large or multinodular HCC underwent liver resection. Clinicopathologic and follow-up data were prospectively collected and retrospectively reviewed. The perioperative and long-term outcomes were analyzed. Univariate and multivariate analysis of prognostic factors were conducted. Although 20 patients had multinodular HCCs, 31 had large solitary tumors. Perioperative mortality occurred in eight patients and complications in 15. In patients with large solitary tumors, 5-year disease-free and overall survival were 41.3 per cent and 56.1 per cent, respectively. Those with multinodular HCCs demonstrated 5-year disease-free and overall survival rates of 0 per cent and 33.6 per cent, respectively. Liver resection can result in long-term survival in select patients with large or multinodular HCCs, even in select patients with impaired liver function. Large solitary HCCs seem to have better prognoses than multinodular tumors, with lower recurrence and higher survival rates after surgery. Randomized controlled trials comparing resection to other treatment modalities are indicated to determine optimal patient management.

Entities:  

Mesh:

Year:  2010        PMID: 21140683

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  8 in total

1.  Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Fei-Xiang Wu; Hang Li
Journal:  Tumour Biol       Date:  2014-09-09

2.  Patients with multiple hepatocellular carcinomas within the UCSF criteria have outcomes after curative resection similar to patients within the BCLC early-stage criteria.

Authors:  Wen-Chao Zhao; Ning Yang; Nan Zhu; Hai-Bin Zhang; Yong Fu; Hua-Bang Zhou; Wen-Ke Cai; Ben-Dong Chen; Guang-Shun Yang
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

3.  Long-term outcomes of liver resection for multiple hepatocellular carcinomas: Single-institution experience with 187 patients.

Authors:  Soo-Young Lee; Chul-Soo Ahn; Young-In Yoon; Sung-Gyu Lee; Shin Hwang; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2020-11-30

4.  Clinical characteristics and survival of European patients with resectable large hepatocellular carcinomas.

Authors:  Felice Giuliante; Agostino Maria De Rose; Vito Guerra; Francesco Ardito; Gennaro Nuzzo; Brian I Carr
Journal:  J Gastrointest Cancer       Date:  2013-09

Review 5.  Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion.

Authors:  Jian-Hong Zhong; A Chapin Rodríguez; Yang Ke; Yan-Yan Wang; Lin Wang; Le-Qun Li
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

Review 6.  Controversies and evidence of hepatic resection for hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Guido Torzilli; Hao Xing; Chao Li; Jun Han; Lei Liang; Han Zhang; Shu-Yang Dai; Le-Qun Li; Feng Shen; Tian Yang
Journal:  BBA Clin       Date:  2016-10-11

7.  Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence.

Authors:  Ye Xin Koh; Hwee Leong Tan; Weng Kit Lye; Juinn Huar Kam; Adrian Kah Heng Chiow; Siong San Tan; Su Pin Choo; Alexander Yaw Fui Chung; Brian Kim Poh Goh
Journal:  World J Hepatol       Date:  2018-06-27

8.  Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.

Authors:  Gui-Qi Zhu; Yi Yang; Er-Bao Chen; Biao Wang; Kun Xiao; Shi-Ming Shi; Zheng-Jun Zhou; Shao-Lai Zhou; Zheng Wang; Ying-Hong Shi; Jia Fan; Jian Zhou; Tian-Shu Liu; Zhi Dai
Journal:  J Transl Med       Date:  2019-06-18       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.